- Home
- / Quest PharmaTech
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Quest PharmaTech financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2024-10-29
Market Capitalization
$4.2 M
2024-10-29
CreditSafe Score
?
Score changed on Jun 10, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CAD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 39.0K | 23.0K | 10.0K | |||||
| Cost of goods sold | 6.0K | 12.0K | 4.0K | |||||
| Gross profit | 33.0K | 11.0K | 6.0K | |||||
| Gross profit margin, % | 84.6% | 47.8% | 60.0% | |||||
| Operating expense total | 7.8M | 9.1M | 13.6M | 1.1M | 751.0K | 821.0K | 1.3M | 819.0K |
| Depreciation and amortization | 12.0K | 42.0K | 39.0K | 13.0K | 3.0K | |||
| EBITDA | (7.8M) | (9.1M) | (13.6M) | (1.1M) | (751.0K) | (821.0K) | (1.3M) | (819.0K) |
| EBITDA margin, % | -19953.8% | -39456.5% | -136460.0% | |||||
| EBIT | (8.1M) | (9.1M) | (13.7M) | 190.1M | (85.0M) | (7.3M) | (3.0M) | (1.3M) |
| EBIT margin, % | -20833.3% | -39673.9% | -136880.0% | |||||
| Interest income | 121.0K | 157.0K | 47.0K | 1.0K | ||||
| Interest expense | 5.0K | 4.0K | 14.0K | 7.0K | 13.0K | 21.0K | 21.0K | 480.0K |
| Pre tax profit | (9.1M) | (8.7M) | (13.3M) | 190.1M | (85.0M) | (7.3M) | (3.0M) | (1.8M) |
| Net Income | (9.1M) | (8.7M) | (13.3M) | 190.1M | (85.0M) | (7.3M) | (3.0M) | (1.8M) |